(4-Bromo-3-fluorophenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → HCID 71252632, compound

HRID 2411436Notes

Reaction equation

HRID 2411436 reaction equation
[CH3:1][C@@H:2]1[CH2:6][S:5](=[O:8])(=[O:7])[NH:4][CH2:3]1.Br[C:10]1[CH:15]=[CH:14][C:13]([C:16]([N:18]2[CH2:23][CH2:22][N:21]([C:24]3[C:29]([CH3:30])=[CH:28][C:27]([CH3:31])=[CH:26][N:25]=3)[CH2:20][CH2:19]2)=[O:17])=[CH:12][C:11]=1[F:32]>>[CH3:30][C:29]1[C:24]([N:21]2[CH2:22][CH2:23][N:18]([C:16]([C:13]3[CH:14]=[CH:15][C:10]([N:4]4[CH2:3][C@H:2]([CH3:1])[CH2:6][S:5]4(=[O:8])=[O:7])=[C:11]([F:32])[CH:12]=3)=[O:17])[CH2:19][CH2:20]2)=[N:25][CH:26]=[C:27]([CH3:31])[CH:28]=1

Participants

3

Procedure

Using (S)-4-methylisothiazolidine 1,1-dioxide (119 mg) described in Preparation Example 4 and (4-bromo-3-fluorophenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (230 mg) described in Preparation Example 125 and by the reaction and treatment in the same manner as in Example 4, the title compound (38 mg) was obtained.

Workup

  1. customdescribed in Preparation Example 125 and by the reaction and treatment in the same manner as in Example 4

Sources & evidence

ORD record
ord-2dbe75616ce441dd9dfcfd0a4ac542b8
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…